Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02825095

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis ; a Prospective Randomized Controlled Study.

Sponsor: Rambam Health Care Campus

Conditions Lung Neoplasms Pleural Effusion, Malignant

Interventions Chest Tube Indwelling Pleural Catheter Local anesthesia Talc Pleurodesis chest ultrasound

Updated 7 times since 2017 Last updated: Jul 6, 2016 Started: Aug 31, 2016 Primary completion: May 31, 2017 Completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Lung Neoplasms and Pleural Effusion, Malignant, this trial is ongoing. The trial is conducted by Rambam Health Care Campus and has accumulated 7 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1
Aug 2018 — Jan 2021 [monthly]

Unknown Status EARLY_PHASE1

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Aug 2018 [monthly]

Not Yet Recruiting EARLY_PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting Phase 0

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rambam Health Care Campus

Data source: Rambam Health Care Campus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.